Searchable abstracts of presentations at key conferences in endocrinology

ea0013p136 | Diabetes, metabolism and cardiovascular | SFEBES2007

Combination therapy with pioglitazone and losartan provides additional renoprotection in subjects with type 2 diabetic nephropathy

Jin Huimin , Pan Yu

Objective: The objective of this study was to determine the efficacy of combination therapy with pioglitazone and losartan in delaying the progression of chronic renal failure in subjects with type 2 diabetic nephropathy.Methods: A randomized, controlled trial was conducted in 60 patients with type 2 diabetic nephropathy. 30 patients received the combination treatment with pioglitazone 30 mg daily and losartan 100 mg daily, and 30 patients received losar...